Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

Authors

Dimitrios Kontoyiannis

Published

March 21, 2005

Abstract

BackgroundAnecdotal evidence suggests a rise in zygomycosis in association with voriconazole (VRC) use in immunosuppressed patients

Supporters

Support the authors with ResearchCoin

Journal

The Journal of Infectious Diseases

Topics

DOI

10.1086/428780

Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

Authors

Dimitrios Kontoyiannis

Published

March 21, 2005

Abstract

BackgroundAnecdotal evidence suggests a rise in zygomycosis in association with voriconazole (VRC) use in immunosuppressed patients

Supporters

Support the authors with ResearchCoin

Journal

The Journal of Infectious Diseases

Topics

DOI

10.1086/428780

Paper

Paper

Paper

Paper

Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

Abstract

Supporters

Journal

Topics

DOI

Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

Abstract

Supporters

Journal

Topics

DOI